Workflow
DEC(600875)
icon
Search documents
11月19日晚间公告 | 合富中国停牌核查结束;德赛西威发布面向机器人领域的AI计算终端
Xuan Gu Bao· 2025-11-19 11:58
Mergers and Acquisitions - Chenyi Intelligent plans to acquire 55% of Huaze Electronics through cash payment [1] - Beijiete's wholly-owned subsidiary intends to acquire 55% of Dahao Mining for 225 million yuan [1] Share Buybacks and Equity Transfers - Chenzhan Optoelectronics' controlling shareholder is transferring 5.02% of shares [2] - Huamin Co., Ltd. plans to transfer 5.17% of shares by Jianxianghuihong [2] - Pro Pharmaceutical intends to repurchase shares worth between 180 million to 360 million yuan, with a maximum price of 23 yuan per share [2] - Ganyue Expressway's actual controller will change from the Provincial Department of Transportation to the Provincial State-owned Assets Supervision and Administration Commission [2] External Investments and Daily Operations - Hefei China has completed its suspension review and resumed trading [3] - Dwei Co., Ltd. is advancing the procedures for lithium battery new energy projects in Hunan Chenzhou [4] - Desay SV plans to launch an AI computing terminal for the robotics sector [4] - Neusoft Group received a notification from a major domestic automotive manufacturer to supply intelligent cockpit domain controllers, with a total expected supply amount of 4.2 billion yuan [4] - Junyi Digital plans to invest 120 million yuan in Guanghong Precision, acquiring 60% ownership post-investment [5] - Dongfang Electric intends to invest 910 million yuan to hold 49% in a joint venture [6] - Bailian Group's subsidiary plans to transfer 100% of its stake in Yangpu Century Bailian for 78.286 million yuan [6] - Ruisheng Intelligent's subsidiary won a bid for a China Mobile ICT project, focusing on computing server hardware and systems [6] - Zhifei Biological's clinical trial application for the ZFA01 adjuvant vaccine has been accepted [7] - Haizheng Pharmaceutical's subsidiary is collaborating with East China Institute on a biomanufacturing project for heparin [8] - Baiyang Pharmaceutical's Zap Therapeutic plans to invest 4.9 million USD in Baiyang Sap to expedite the clinical introduction of the ZAP-X Mars surgical robot [8] - Jinbei Automotive plans to invest 5.8 billion yuan and purchase equity in Changchun Zhongtuo Molding Technology [9] - Baili Tianheng has secured a commitment from Bank of China Sichuan Branch for a total of no less than 8 billion yuan in comprehensive credit support [10]
The Goldman Sachs Group, Inc.增持东方电气49.7万股 每股作价约22.42港元
Zhi Tong Cai Jing· 2025-11-19 11:22
香港联交所最新资料显示,11月14日,The Goldman Sachs Group,Inc.增持东方电气(600875) (01072)49.7万股,每股作价22.4239港元,总金额约为1114.47万港元。增持后最新持股数目约为2073.19 万股,最新持股比例为5.08%。 ...
The Goldman Sachs Group, Inc.增持东方电气(01072)49.7万股 每股作价约22.42港元
智通财经网· 2025-11-19 11:16
智通财经APP获悉,香港联交所最新资料显示,11月14日,The Goldman Sachs Group, Inc.增持东方电气 (01072)49.7万股,每股作价22.4239港元,总金额约为1114.47万港元。增持后最新持股数目约为2073.19 万股,最新持股比例为5.08%。 ...
东方电气:东方风电与皖能能源拟共同成立合资公司 推进东方电气木垒100万千瓦科技创新实
Zhi Tong Cai Jing· 2025-11-19 10:35
Core Viewpoint - The company is responding to policy changes and market competition by forming a joint venture with Anhui Energy, aiming to enhance its operational capabilities in wind power and align with national carbon neutrality goals [1] Group 1: Joint Venture Formation - Dongfang Electric's subsidiary, Dongfang Wind Power, will invest in a joint venture by contributing 100% equity of Muli Dongji, valued at approximately 909.85 million yuan [1] - Anhui Energy will hold a 51% stake in the joint venture, while Dongfang Wind Power will hold 49% [1] - The registered capital of the joint venture is approximately 1.86 billion yuan [1] Group 2: Strategic Goals - The partnership aims to optimize state-owned capital layout and promote professional integration, resource complementarity, and strategic collaboration [1] - This initiative is in line with the national "dual carbon" strategy, which seeks to enhance development quality and mitigate risks [1] Group 3: Financial Implications - Following the transaction, Muli Dongji will no longer be included in the company's consolidated financial statements [1] - The transaction is expected to increase the company's total profit in 2025, with specific figures pending audit results [1]
11月19日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-19 10:32
Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]
东方电气:董事会批准东方国际无偿划转东方设计19.43%股权
Ge Long Hui· 2025-11-19 10:04
Core Viewpoint - The company announced the board's approval for the transfer of a portion of equity in its subsidiary, Oriental Design, from Oriental International to the company without compensation, indicating a strategic move to consolidate ownership and enhance operational efficiency [1] Group 1: Equity Transfer Details - Oriental International will transfer 19.4289% of its equity in Oriental Design to the company without compensation [1] - The transfer is based on an audit report confirming the value of the state-owned property at approximately 65.1964 million yuan, with the transfer reference date set for March 31, 2025 [1]
东方电气(01072):东方风电与皖能能源拟共同成立合资公司 推进东方电气木垒 100 万千瓦科技创新实验风场项目
智通财经网· 2025-11-19 09:57
Core Viewpoint - The company is responding to policy changes and market competition by forming a joint venture with a strategic partner to enhance its operational capabilities in wind power generation [1][2] Group 1: Joint Venture Formation - The company’s subsidiary, Dongfang Wind Power, will invest in a joint venture by contributing 100% equity of Muli Dongji, with the aim of advancing the 1 million kW technology innovation experimental wind farm project [1] - The joint venture will be established with Waneng Energy, where Dongfang Wind Power holds 49% and Waneng Energy holds 51% [1] - The registered capital of the joint venture is approximately 1.85683 billion yuan, with the equity value of Muli Dongji assessed at approximately 909.85 million yuan [1] Group 2: Strategic Objectives - The introduction of a strategic partner aligns with the national "dual carbon" strategy, optimizing the layout of state-owned capital and promoting professional integration [2] - The transaction is expected to enhance the quality of development for Dongfang Wind Power and is projected to increase the company's total profit in 2025, subject to audit results [2]
东方电气:东方风电与皖能能源拟共同成立合资公司 推进东方电气木垒 100 万千瓦科技创新实验风场项目
Zhi Tong Cai Jing· 2025-11-19 09:54
Core Viewpoint - Dongfang Electric (600875) is responding to policy changes and market competition by forming a joint venture with Anhui Energy, aiming to enhance its wind farm operational capabilities and mitigate investment risks through strategic collaboration [1] Group 1: Joint Venture Formation - Dongfang Electric's subsidiary, Dongfang Wind Power, will invest in a joint venture by contributing 100% equity of Muli Dongji, valued at approximately 90,984.68 million yuan, while Anhui Energy will contribute 94,698.3405 million yuan in cash [1] - The joint venture will have a registered capital of 185,683.0205 million yuan, with Dongfang Wind Power holding 49% and Anhui Energy holding 51% [1] Group 2: Strategic Objectives - The partnership aims to align with the national "dual carbon" strategy, optimize state capital layout, and promote professional integration and resource complementarity [1] - The transaction is expected to enhance the quality of development for Dongfang Wind Power and is projected to increase the company's total profit in 2025, subject to audit results [1]
东方电气(01072.HK):董事会批准东方风电以木垒东吉100%股权作价参股合资公司 持股49%
Ge Long Hui A P P· 2025-11-19 09:52
格隆汇11月19日丨东方电气(01072.HK)发布公告,董事会会议审议通过东方风电以木垒东吉新能源有限 公司100%股权作价参股投资成立合资公司的议案。公司控股子公司东方电气风电股份有限公司(简称 东方风电)以木垒东吉新能源有限公司100%股权作价参股投资成立合资公司已经董事会战略发展委员 会审议通过并同意提交董事会审议。董事会同意东方风电以木垒东吉新能源有限公司100%股权作价参 股投资成立合资公司,投资金额90,984.68万元(实际金额以经备案的资产评估结果为准),东方风电持 股49%。 ...
东方电气(01072.HK):董事会批准东方国际无偿划转东方设计19.43%股权
Ge Long Hui A P P· 2025-11-19 09:52
格隆汇11月19日丨东方电气(01072.HK)发布公告,董事会会议审议通过东方国际向公司无偿划转东方设 计部分股权的议案,公司全资子公司东方电气集团国际合作有限公司(简称东方国际)向公司无偿划转 东方电气集团电力工程设计有限公司(简称东方设计)部分股权已经董事会战略发展委员会审议通过并 同意提交董事会审议。董事会同意东方国际向公司无偿划转东方设计19.4289%股权,以东方设计划转 基准日的审计报告为基础确认无偿划转国有产权价值(折约6519.64万元),划转基准日为2025年3月31 日。 ...